Stomatitis clinical trials

Explore recruiting stomatitis clinical trials.

Recruiting stomatitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Stomatitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Open-label single-arm, multicenter clinical trial to evaluate patient acceptability of a new CREON formulation of Pancreas Powder gastro-resistant pellets in patients with cystic fibrosis suffering from pancreatic exocrine insufficiency.

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Long-Term Follow-Up (LTFU) of Participants Treated with Adoptive Cell Therapies

Netherlands, Spain, Italy

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase II, Randomized, Open-Label Study Evaluating Two Inavolisib Dose Levels in Combination with Fulvestrant in Participants with PIK3CA-Mutated, HR-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

Belgium, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized double blind controlled trial comparing the safety and efficacy of apremilast versus placebo in severe forms of recurrent aphthous stomatitis - PREMS - 2019/0411/HP

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

CAPTIRALL _ Combination of an Anti-PD1 antibody with Tisagenlecleucel Reinfusion in children, adolescents and young adults with Acute Lymphoblastic Leukemia after loss of persistence

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A single-arm, open-label, multi-centre, phase I/II study evaluating the safety and clinical activity of QEL-001, an autologous CAR T regulatory cell treatment targeting HLA-A2, in HLA-A2/ A28neg patients that have received an HLA-A2pos liver transplant.

Belgium, Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Stomatitis trials by city

Stomatitis in Toronto Stomatitis in Vancouver Stomatitis in Montreal Stomatitis in Calgary Stomatitis in Edmonton Stomatitis in Ottawa Stomatitis in Winnipeg Stomatitis in Quebec City Stomatitis in Hamilton Stomatitis in Kitchener Stomatitis in London Stomatitis in Halifax Stomatitis in New York Stomatitis in Los Angeles Stomatitis in Chicago Stomatitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease